BMRN vs CSTL · P/E 40, rev $1.76B vs rev $187.2M
Biomarin Pharmaceutical Inc (BMRN) versus Castle Biosciences Inc (CSTL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CSTL currently screens at market cap $570.2M.
Not investment advice. Open the BMRN and CSTL stock pages for the full models.
Not investment advice.